Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

Blood

Volumn 100, Issue 12, 2002, Pages 3887-3896

  Ogata, Kiyoyuki ^{a,b,c,d,e,f,g,h}   Nakamura, Kyoko ^{a,b,c,d,e,f,g,h}   Yokose, Norio ^{a,b,c,d,e,f,g,h}   Tamura, Hideto ^{a,b,c,d,e,f,g,h}   Tachibana, Mikiko ^{a,b,c,d,e,f,g,h}   Taniguchi, Osamu ^{a,b,c,d,e,f,g,h}   Iwakiri, Rika ^{a,b,c,d,e,f,g,h}   Hayashi, Tatsuyuki ^{a,b,c,d,e,f,g,h}   Sakamaki, Hisashi ^{a,b,c,d,e,f,g,h}   Murai, Yoshiro ^{a,b,c,d,e,f,g,h}   Tohyama, Kaoru ^{a,b,c,d,e,f,g,h}   Tomoyasu, Shigeru ^{a,b,c,d,e,f,g,h}   Nonaka, Yasunobu ^{a,b,c,d,e,f,g,h}   Mori, Mayumi ^{a,b,c,d,e,f,g,h}   Dan, Kazuo ^{a,b,c,d,e,f,g,h}   Yoshida, Yataro ^{a,b,c,d,e,f,g,h}  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e Tokyo Metropolitan Tama Geriatric Hospital   (Japan)

^f SHOWA UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h Inariyama Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD7 ANTIGEN; CELL MARKER; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; BLOOD SAMPLING; BONE MARROW CELL; CANCER RISK; CELL MATURATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOCHEMISTRY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGICAL TRAIT; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA;

EID: 0036891859     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0222     Document Type: Article

References (47)

1. Yoshida Y, Stephenson J, Mufti GJ. Myelodysplastic syndromes: From morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Int J Hematol. 1993;57:87-97.
2. Stephenson J, Mufti GJ, Yoshida Y. Myelodysplastic syndromes: From morphology to molecular biology. Part II. The molecular genetics of myelodysplasia. Int J Hematol. 1993;57:99-112.
3. Aul C, Bowen DT, Yoshida Y. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica. 1998;83:71-86.
4. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
5. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
6. Albitar M, Beran M, O'Brien S, et al. Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia. Blood. 2000;96:372-373.
7. Nosslinger T, Reisner R, Koller E, et al. Myelodysplastic syndromes, from French-American-.British to World Health Organization: Comparison of classifications on 431 unselected patients from a single institution. Blood. 2001;98:2935-2941.
8. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89: 2079-2088.
9. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98:979-987.
10. Masuya M, Kita K, Shimizu N, et al. Biologic characteristics of acute leukemia after myelodysplastic syndrome. Blood. 1993;81:3388-3394.
11. Oertel J, Kleiner S, Huhn D. Immunotyping of blasts in refractory anaemia with excess of blasts. Br J Haematol. 1993;84:305-309.
12. Baur AS, Meuge MC, Schmidt PM, Parlier V, Jotterand M, Delacretaz F. CD34/QBEND10 immunostaining in bone marrow biopsies: An additional parameter for the diagnosis and classification of myelodysplastic syndromes. Eur J Haematol. 2000;64:71-79.
13. Sievers EL, Appelbaum FR, Spielberger RT, et al. Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. 1999;93:3678-3684.
14. Smolich BD, Yuen HA, West KA, Giles FJ, Albitar M, Cherrington JM. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. Blood. 2001;97:1413-1421.
15. Ogata K. A simple centrifugation method for harvesting myeloblasts. Int J Hematol. 2001;74:272-276.
16. Ogata K. Usefulness of a novel Blastretriever for harvesting blasts. Nippon Rinsho. 2001;59:2353-2357.
17. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American British Cooperative Group. Ann Intern Med. 1985;103:620-625.
18. Mitelman F. ISCN 1995: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995.
19. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis: Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100: 534-540.
20. Ogata K, Yokose N, Shioi Y, et al. Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia. Br J Haematol. 2001;115:612-615.
21. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow, II: Normal B lymphocyte development. Blood. 1987; 70:1316-1324.
22. Stelzer GT, Goodpasture L. Use of multiparameter flow cytometry and immunophenotyping for the diagnosis and classification of acute myeloid leukemia. In: Stewart CC, Nicholson JKA, eds. Immunophenotyping. New York, NY: Wiley-Liss; 2000:215-238.
23. Loken MR, Wells DA. Normal antigen expression in hematopoiesis: Basis for interpreting leukemia phenotypes. In: Stewart CC, Nicholson JKA, eds. Immunophenotyping. New York, NY: Wiley-Liss; 2000:133-160.
24. + cells for the detection of minimal residual disease in adult acute myeloid leukaemia. Br J Haematol. 2000; 108:710-716.
25. Cossman J, Neckers LM, Leonard WJ, Greene WC. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J Exp Med. 1983;157:1064-1069.
26. + myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity. Blood. 1997;90:2417-2428.
27. Ema H, Suda T, Miura Y, Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood. 1990;75:1941-1946.
28. + haematopoietic progenitor cells. Br J Haematol. 1993;84:24-30.
29. + cells: An adverse prognostic factor in the myelodysplastic syndromes. Am J Hematol. 1992;39:96-101.
30. Soligo DA, Oriani A, Annaloro C, et al. CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes. Am J Hematol. 1994;46:9-17.
31. Oriani A, Annaloro C, Soligo D, Pozzoli E, Cortelezzi A, Lambertenghi DG. Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes. Br J Haematol. 1996;92:360-364.
32. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia. 1994;8:823-826.
33. Bradstock K, Matthews J, Benson E, Page F, Bishop J. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group. Blood. 1994;84:1220-1225.
34. Wang JC, Beauregard P, Soamboonsrup P, Neame PB. Monoclonal antibodies in the management of acute leukemia. Am J Hematol. 1995; 50:188-199.
35. Venditti A, Del PG, Buccisano F, et al. Minimally differentiated acute myeloid leukemia (AML-M0): Comparison of 25 cases with other French-American-British subtypes. Blood. 1997;89:621-629.
36. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. The immunophenotype of adult acute myeloid leukemia: High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol. 1998;109:211-220.
37. Cuneo A, Ferrant A, Michaux JL, et al. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: Correlation with clinicobiologic findings. Blood. 1995;85:3688-3694.
38. Estey E, Kantarjian H, Cortes J, Giles F, Beran M. Chemotherapy for high-risk MDS: MD Anderson approaches [abstract]. Leuk Res. 2001;25(suppl 1):S17.
39. Mesters RM, Padro T, Bieker R, et al. Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood. 2001; 98:241-243.
40. Chabannon C, Wood P, Torok SB. Expression of CD7 on normal human myeloid progenitors. J Immunol. 1992;149:2110-2113.
41. + bone marrow cells. J Exp Med. 1993;177:1531-1539.
42. Tien HF, Wang CH. CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia. Leuk Lymphoma. 1998;31:93-98.
43. Lo Coco F, De Rossi G, Pasqualetti D, et al. CD7 positive acute myeloid leukaemia: A subtype associated with cell immaturity. Br J Haematol. 1989;73:480-485.
44. Carrera AC, Rincon M, Sanchez-Madrid F, Lopez-Botet M, de Landazuri MO. Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies. J Immunol. 1988;141:1919-1924.
45. Carrel S, Salvi S, Rafti F, Favrot M, Rapin C, Sekaly RP. Direct involvement of CD7 (gp40) in activation of TcR gamma/delta+ T cells. Eur J Immunol. 1991;21:1195-1200.
46. Shimizu Y, van Seventer G, Ennis E, Newman W, Horgan KJ, Shaw S. Crosslinking of the T cell specific accessory molecules CD7 and CD28 modulates T cell adhesion. J Exp Med. 1992;175: 577-582.
47. Hou Z, Leta E, Jung LK. Cross-linking CD7 on myeloblasts results in granulocyte-macrophage colony-stimulating factor production. Blood. 1996; 124-129